List of Tables
Table 1. Global C1 Esterase Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global C1 Esterase Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global C1 Esterase Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global C1 Esterase Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global C1 Esterase Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global C1 Esterase Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global C1 Esterase Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market C1 Esterase Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of C1 Esterase Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of C1 Esterase Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of C1 Esterase Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of C1 Esterase Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global C1 Esterase Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on C1 Esterase Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global C1 Esterase Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global C1 Esterase Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global C1 Esterase Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global C1 Esterase Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global C1 Esterase Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global C1 Esterase Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global C1 Esterase Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global C1 Esterase Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global C1 Esterase Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America C1 Esterase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America C1 Esterase Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America C1 Esterase Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America C1 Esterase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America C1 Esterase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe C1 Esterase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe C1 Esterase Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe C1 Esterase Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe C1 Esterase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe C1 Esterase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific C1 Esterase Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific C1 Esterase Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific C1 Esterase Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific C1 Esterase Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific C1 Esterase Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America C1 Esterase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America C1 Esterase Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America C1 Esterase Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America C1 Esterase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America C1 Esterase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa C1 Esterase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa C1 Esterase Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa C1 Esterase Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa C1 Esterase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa C1 Esterase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global C1 Esterase Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global C1 Esterase Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global C1 Esterase Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global C1 Esterase Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global C1 Esterase Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global C1 Esterase Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global C1 Esterase Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global C1 Esterase Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global C1 Esterase Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global C1 Esterase Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global C1 Esterase Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global C1 Esterase Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global C1 Esterase Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global C1 Esterase Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global C1 Esterase Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global C1 Esterase Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global C1 Esterase Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global C1 Esterase Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global C1 Esterase Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global C1 Esterase Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. CSL Behring Company Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring C1 Esterase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. CSL Behring C1 Esterase Inhibitors Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Takeda Company Information
Table 76. Takeda Description and Business Overview
Table 77. Takeda C1 Esterase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Takeda C1 Esterase Inhibitors Product
Table 79. Takeda Recent Developments/Updates
Table 80. Pharming Healthcare Company Information
Table 81. Pharming Healthcare Description and Business Overview
Table 82. Pharming Healthcare C1 Esterase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Pharming Healthcare C1 Esterase Inhibitors Product
Table 84. Pharming Healthcare Recent Developments/Updates
Table 85. Key Raw Materials Lists
Table 86. Raw Materials Key Suppliers Lists
Table 87. C1 Esterase Inhibitors Distributors List
Table 88. C1 Esterase Inhibitors Customers List
Table 89. C1 Esterase Inhibitors Market Trends
Table 90. C1 Esterase Inhibitors Market Drivers
Table 91. C1 Esterase Inhibitors Market Challenges
Table 92. C1 Esterase Inhibitors Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Product Picture of C1 Esterase Inhibitors
Figure 2. Global C1 Esterase Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global C1 Esterase Inhibitors Market Share by Type: 2025 & 2032
Figure 4. Recombinant C1-INH Product Picture
Figure 5. Plasma-derived C1-INH Product Picture
Figure 6. Global C1 Esterase Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 7. Global C1 Esterase Inhibitors Market Share by Application: 2025 & 2032
Figure 8. Hospital and Clinic
Figure 9. Pharmacy
Figure 10. Other
Figure 11. Global C1 Esterase Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global C1 Esterase Inhibitors Market Size (US$ Million), 2021–2032
Figure 13. Global C1 Esterase Inhibitors Sales (K Units), 2021–2032
Figure 14. Global C1 Esterase Inhibitors Average Price (US$/Unit), 2021–2032
Figure 15. C1 Esterase Inhibitors Report Years Considered
Figure 16. C1 Esterase Inhibitors Sales Share by Manufacturers in 2025
Figure 17. Global C1 Esterase Inhibitors Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global C1 Esterase Inhibitors Players: Market Share by Revenue in C1 Esterase Inhibitors in 2025
Figure 19. C1 Esterase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global C1 Esterase Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America C1 Esterase Inhibitors Sales Market Share by Country (2021–2032)
Figure 22. North America C1 Esterase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 23. United States C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe C1 Esterase Inhibitors Sales Market Share by Country (2021–2032)
Figure 26. Europe C1 Esterase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 27. Germany C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific C1 Esterase Inhibitors Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific C1 Esterase Inhibitors Revenue Market Share by Region (2021–2032)
Figure 34. China C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America C1 Esterase Inhibitors Sales Market Share by Country (2021–2032)
Figure 42. Latin America C1 Esterase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 43. Mexico C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa C1 Esterase Inhibitors Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa C1 Esterase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 49. Turkey C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE C1 Esterase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of C1 Esterase Inhibitors by Type (2021–2032)
Figure 53. Global Revenue Market Share of C1 Esterase Inhibitors by Type (2021–2032)
Figure 54. Global C1 Esterase Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of C1 Esterase Inhibitors by Application (2021–2032)
Figure 56. Global Revenue Market Share of C1 Esterase Inhibitors by Application (2021–2032)
Figure 57. Global C1 Esterase Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 58. C1 Esterase Inhibitors Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
